ATE403149T1 - Diagnostische tests auf periostinbasis - Google Patents

Diagnostische tests auf periostinbasis

Info

Publication number
ATE403149T1
ATE403149T1 AT02757081T AT02757081T ATE403149T1 AT E403149 T1 ATE403149 T1 AT E403149T1 AT 02757081 T AT02757081 T AT 02757081T AT 02757081 T AT02757081 T AT 02757081T AT E403149 T1 ATE403149 T1 AT E403149T1
Authority
AT
Austria
Prior art keywords
periostin
diagnostic tests
based diagnostic
human periostin
preeclempsia
Prior art date
Application number
AT02757081T
Other languages
English (en)
Inventor
Lan Bo Chen
Meiru Dai
Hidefumi Sasaki
Daniel Auclair
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of ATE403149T1 publication Critical patent/ATE403149T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
AT02757081T 2001-08-13 2002-08-13 Diagnostische tests auf periostinbasis ATE403149T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31212301P 2001-08-13 2001-08-13

Publications (1)

Publication Number Publication Date
ATE403149T1 true ATE403149T1 (de) 2008-08-15

Family

ID=23209980

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02757081T ATE403149T1 (de) 2001-08-13 2002-08-13 Diagnostische tests auf periostinbasis

Country Status (8)

Country Link
US (2) US7087727B2 (de)
EP (1) EP1442295B1 (de)
JP (1) JP2005500059A (de)
AT (1) ATE403149T1 (de)
AU (1) AU2002323120A1 (de)
CA (1) CA2457065A1 (de)
DE (1) DE60227974D1 (de)
WO (1) WO2003016471A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1524524A1 (de) * 1998-12-18 2005-04-20 Scios Inc. Methode zur Detektion und Verwendung von differentiel exprimiertem OSF-2 in der Diagnose von Herzhypertrophie
ATE403149T1 (de) * 2001-08-13 2008-08-15 Dana Farber Cancer Inst Inc Diagnostische tests auf periostinbasis
US7601505B2 (en) 2003-05-29 2009-10-13 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
IL177006A0 (en) * 2005-08-02 2006-12-10 Veridex Llc Predicting bone relapse of breast cancer
ATE461215T1 (de) * 2005-09-05 2010-04-15 Immatics Biotechnologies Gmbh Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden
US8017119B2 (en) 2005-12-28 2011-09-13 Daiichi Sankyo Company, Ltd. Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
EP1806587A1 (de) * 2006-01-07 2007-07-11 Université de Liège In-vitro-Verfahren zum Screening zugänglicher biologischer Marker in pathologischen Geweben
EP1987359B1 (de) 2006-02-22 2015-03-18 Philogen S.p.A. Marker für gefässtumore
JP5238942B2 (ja) * 2007-06-27 2013-07-17 国立大学法人大阪大学 ペリオスチンのＥｘｏｎ−１７部位によりコードされるペプチドに対する抗体を含む癌治療剤
WO2009075883A2 (en) * 2007-12-12 2009-06-18 University Of Georgia Research Foundation, Inc. Glycoprotein cancer biomarker
JP5717178B2 (ja) 2008-06-05 2015-05-13 国立大学法人佐賀大学 特発性間質性肺炎の検出方法
JP5632994B2 (ja) * 2008-12-19 2014-12-03 国立大学法人佐賀大学 非特発性間質性肺炎の治療薬のスクリーニング方法
FR2946349B1 (fr) * 2009-06-03 2013-10-04 Synarc Sas Sequences, anticorps, procedes et necessaires pour la detection et le dosage in vitro de la periostine, en vue du diagnostic du suivi ou du pronostic de pathologies ou de phenomenes biologiques impliquant la periostine
JP5885243B2 (ja) * 2009-12-02 2016-03-15 国立大学法人佐賀大学 胆管細胞癌の検出方法および予防・治療剤のスクリーニング方法
JP5555940B2 (ja) * 2010-04-14 2014-07-23 国立大学法人佐賀大学 増殖糖尿病網膜症の検出方法および予防・治療剤のスクリーニング方法
JP2012058048A (ja) * 2010-09-08 2012-03-22 Shino Test Corp ペリオスチン測定の正確性の改善方法
JP6005657B2 (ja) 2010-12-16 2016-10-12 ジェネンテック， インコーポレイテッド Ｔｈ２阻害に関連する診断及び治療
US20140080128A1 (en) 2011-05-18 2014-03-20 Institut National de Ia Sante et de la Recherche Medicale (INSERM) Method for determining whether a subject is at risk of having or developing a chronic kidney disease
EP2754672B1 (de) 2011-09-06 2019-02-27 Shino-Test Corporation Antikörper zur bindung an eine spezifische region von periostin sowie verfahren zur periostinmessung damit
WO2013038696A1 (ja) * 2011-09-15 2013-03-21 国立大学法人名古屋大学 胸膜中皮腫患者の早期発見のための分子マーカー及びその発現解析方法
JP5871228B2 (ja) * 2011-10-31 2016-03-01 国立大学法人佐賀大学 慢性副鼻腔炎の検出方法
US9198900B2 (en) 2011-11-10 2015-12-01 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Treatment of peritoneal injury using JAK inhibitors
ES2811060T3 (es) * 2013-03-08 2021-03-10 Univ Osaka Anticuerpo contra péptido codificado por exón-21 de periostina y composición farmacéutica para prevenir o tratar enfermedades asociadas a inflamación que contienen el mismo
WO2014153442A2 (en) * 2013-03-21 2014-09-25 The General Hospital Corporation Methods and systems for treatment of ovarian cancer
SI3456339T1 (sl) 2013-08-05 2022-01-31 Immatics Biotechnologies Gmbh Nova imunoterapija proti več tumorjem, kot je pljučni rak, vključno z nedrobnoceličnim pljučnim rakom
TWI714869B (zh) * 2013-08-05 2021-01-01 德商伊瑪提克斯生物科技有限公司 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物
US11085932B2 (en) * 2015-10-08 2021-08-10 Universite De Geneve Periostin fragments and use thereof
KR101888193B1 (ko) * 2016-02-19 2018-08-13 이화여자대학교 산학협력단 유방암 전이 진단 지표로서의 혈중 페리오스틴
CN106520771B (zh) * 2016-12-20 2019-02-12 江苏省人民医院 一种长非编码rna及其在诊断/治疗子痫前期中的应用
WO2019183131A1 (en) * 2018-03-19 2019-09-26 Bioventures, Llc Periostin antibodies and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05268982A (ja) * 1992-03-27 1993-10-19 Hoechst Japan Ltd 骨形成作用を有する新規な蛋白質およびその製造法
CA2175380A1 (en) * 1993-10-29 1995-05-04 Lan Bo Chen A novel tumor marker and novel method of isolating same
AU744087B2 (en) * 1997-05-29 2002-02-14 Board Of Regents, The University Of Texas System OSF2/CBFA1 compositions and methods of use
AU2055300A (en) 1998-12-18 2000-07-03 Scios Inc. Methods for detection and use of differentially expressed genes in disease states
WO2001057062A1 (en) * 2000-02-03 2001-08-09 Gene Logic, Inc. Modulation of osf-2 in inflammatory and renal diseases
ATE403149T1 (de) * 2001-08-13 2008-08-15 Dana Farber Cancer Inst Inc Diagnostische tests auf periostinbasis

Also Published As

Publication number Publication date
EP1442295B1 (de) 2008-07-30
EP1442295A2 (de) 2004-08-04
WO2003016471A3 (en) 2003-08-21
AU2002323120A1 (en) 2003-03-03
JP2005500059A (ja) 2005-01-06
WO2003016471A2 (en) 2003-02-27
US20030073137A1 (en) 2003-04-17
DE60227974D1 (de) 2008-09-11
US7087727B2 (en) 2006-08-08
CA2457065A1 (en) 2003-02-27
US20060228763A1 (en) 2006-10-12
EP1442295A4 (de) 2005-08-17

Similar Documents

Publication Publication Date Title
ATE403149T1 (de) Diagnostische tests auf periostinbasis
EP1363920A4 (de) Modifizierte psma-liganden und deren verwendung
ATE470723T1 (de) Genexpressionsmarker für die prognose von brustkrebs
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
AR037223A1 (es) Anticuerpos bloqueadores de cripto, composiciones que los comprenden, y metodos que los utilizan
CY1112101T1 (el) Νευροτροφικοι παραγοντες
BRPI0414513A (pt) kid3 e anticorpos de kid3 que se ligam a ele
MXPA05011755A (es) Composiciones y metodos para inmunoterapia especifica de tumor wilms 1.
DE60219419D1 (de) Flt4 (vegfr-3) als ein ziel für krebs darstellung und anti-krebs-behandlung
MXPA04006517A (es) Conjugados que comprenden un anticuerpo especifico para el dominio ed-b de fibronectina y sus usos para la deteccion y tratamiento de tumores.
PT1557462E (pt) Células de indução da aceitação de um transplante de origem monocítica e a sua preparação e utilização
DE60321041D1 (de) Antikörper gegen krebsantigen tmeff2 und seine anwendungen
IL191982A0 (en) Breast cancer resistance protein (bcrp) and the dna which encodes it
CR10212A (es) Modulacion de la formacion osea
ATE470672T1 (de) Verwendung von cupredoxin-proteine für krebstherapie
IL151448A0 (en) Proteins
ATE470478T1 (de) An ovarialkrebs beteiligtes protein
WO2004040312A3 (fr) Proceded de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
ATE420365T1 (de) Präparierung von sphären für diagnostische tests
IL207012A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
ATE313551T1 (de) Isoliertes nukleinsäuremolekül, das die tumorabstossungs-antigenvorläufer mage- c1 und mage-c2 kodiert und seine verwendung
AU2001235761A1 (en) Diagnosis of breast cancer using bcmp-11 as marker
ATE328899T1 (de) Zellkernlokalisierendes protein für beta-catenin
UY26170A1 (es) Antigeno (c42) asociados a tumores

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties